微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -53.9% | 97.88% | -155.6% | 148/157 | 50.55% | 泽璟制药 | 94.64% | 行业排名> |
| 2025-12-31 | 96.93% | -2.05% | 101.25% | 2/157 | 50.61% | 海创药业 | 99.82% | 行业排名> |
| 2025-09-30 | -7738.36% | -83.81% | -48.28% | 146/157 | -2.2% | 海创药业 | 98.62% | 行业排名> |
| 2025-06-30 | -5218.59% | -92.81% | -105.65% | 147/157 | 14.83% | 海创药业 | 99.57% | 行业排名> |
| 2025-03-31 | -2537.55% | 2% | -2664.32% | 144/157 | 31.96% | 海创药业 | 99.52% | 行业排名> |
| 2024-12-31 | 98.96% | 1.11% | 102.35% | 1/157 | 51.88% | 艾力斯 | 96.74% | 行业排名> |
| 2024-09-30 | -4209.95% | -54.72% | -55.54% | 147/157 | 22.51% | 首药控股 | 98.96% | 行业排名> |
| 2024-06-30 | -2706.65% | -45.34% | -2865.52% | 147/157 | 33.12% | 迪哲医药 | 97.73% | 行业排名> |
| 2023-12-31 | 97.87% | -1.51% | 103.6% | 2/157 | 51.61% | 百利天恒 | 97.99% | 行业排名> |
| 2023-09-30 | -2721.01% | 59.23% | -46.11% | 145/157 | 32.47% | 百利天恒 | 98.92% | 行业排名> |
| 2023-06-30 | -1862.28% | 60.46% | -1974.06% | 145/157 | 38.42% | 迈威生物 | 98.93% | 行业排名> |
| 2022-12-31 | 99.37% | -0.56% | 101.49% | 2/157 | 53.83% | 迈威生物 | 99.59% | 行业排名> |
| 2022-09-30 | -6674.82% | -606.56% | -41.73% | 139/157 | 5.64% | 迈威生物 | 99.8% | 行业排名> |
| 2022-06-30 | -4709.52% | -373.71% | -4812.71% | 144/157 | 20.99% | 迈威生物 | 99.46% | 行业排名> |
| 2021-12-31 | 99.93% | -0.01% | 110.58% | 1/157 | 55.2% | 迈威生物 | 99.75% | 行业排名> |
| 2021-09-30 | -944.69% | -1045.25% | 4.98% | 131/157 | 46.77% | 迈威生物 | 99.67% | 行业排名> |
| 2021-06-30 | -994.19% | 2% | -1094.77% | 139/157 | 47.23% | 迈威生物 | 99.44% | 行业排名> |
| 2020-12-31 | 99.94% | 2% | 0% | 1/157 | -148.64% | 迈威生物 | 98.57% | 行业排名> |
| 2020-09-30 | 99.94% | 2% | 2% | 2/157 | 56.43% | 首药控股 | 99.93% | 行业排名> |